Molecular response to first line nilotinib in a patient with e19a2 BCR-ABL1 chronic myeloid leukemia

被引：9
|
作者：
Langabeer, Stephen E. [1 ]
McCarron, Sarah L.
Carroll, Peig
Kelly, Johanna [2 ]
O'Dwyer, Michael [3 ]
Conneally, Eibhlin [4 ]
机构：
[1] St James Hosp, Cent Pathol Lab, Dublin 8, Ireland
[2] Our Ladys Childrens Hosp, Natl Ctr Med Genet, Dublin, Ireland
[3] Natl Univ Ireland, Dept Haematol, Galway, Ireland
[4] St James Hosp, Dept Haematol, Dublin 8, Ireland
来源：
LEUKEMIA RESEARCH | 2011年 / 35卷 / 09期
关键词：
IMATINIB; MUTATION; DISEASE;
D O I：
10.1016/j.leukres.2011.05.010
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E169 / E170
页数：2
相关论文
共 50 条
  • [31] Impact of second decline rate of BCR-ABL1 transcript on clinical outcome of chronic phase chronic myeloid leukemia patients on imatinib first-line
    Dulucq, Stephanie
    Etienne, Gabriel
    Morisset, Stephane
    Klein, Emilie
    Chollet, Claudine
    Robbesyn, Fanny
    Turcq, Beatrice
    Tigaud, Isabelle
    Hayette, Sandrine
    Nicolini, Franck E.
    Mahon, Francois-Xavier
    ANNALS OF HEMATOLOGY, 2019, 98 (05) : 1159 - 1168
  • [32] Consensus on BCR-ABL1 reporting in chronic myeloid leukaemia in the UK
    Cross, Nicholas C. P.
    White, Helen E.
    Evans, Paul A. S.
    Hancock, Jeremy
    Copland, Mhairi
    Milojkovic, Dragana
    Mason, Joanne
    Craine, Sandra
    Mead, Adam J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 (06) : 777 - 788
  • [33] Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia
    Foroni, Letizia
    Wilson, Gill
    Gerrard, Gareth
    Mason, Joanne
    Grimwade, David
    White, Helen E.
    de Castro, David Gonzalez
    Austin, Stephen
    Awan, Abida
    Burt, Emma
    Clench, Tim
    Farruggia, Joanna
    Hancock, Jeremy
    Irvine, Alexandra E.
    Kizilors, Aytug
    Langabeer, Stephen
    Milner, Benedict J.
    Nickless, Guillermina
    Schuh, Anna
    Sproul, Anne
    Wang, Lihui
    Wickham, Caroline
    Cross, Nicholas C. P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 (02) : 179 - 190
  • [34] Analytical Validation of a Highly Sensitive, Multiplexed Chronic Myeloid Leukemia Monitoring System Targeting BCR-ABL1 RNA
    Brown, Justin T.
    Beldorth, Ion J.
    Laosinchai-Wolf, Walairat
    Fahey, Marie E.
    Jefferson, Ken L.
    Ruskin, Adam K.
    Roth, Jacquelyn J.
    Cai, Li
    Watt, Christopher D.
    Press, Richard D.
    Yang, Fei
    Hedges, John B.
    Andruss, Bernard F.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (04) : 718 - 733
  • [35] Targeting BCR-ABL1 in Chronic Myeloid Leukemia by PROTAC-Mediated Targeted Protein Degradation
    Burslem, George M.
    Schultz, Anna Reister
    Bondeson, Daniel P.
    Eide, Christopher A.
    Stevens, Samantha L. Savage
    Druker, Brian J.
    Crews, Craig M.
    CANCER RESEARCH, 2019, 79 (18) : 4744 - 4753
  • [36] Genetic alterations in the BCR-ABL1 fusion gene related to imatinib resistance in chronic myeloid leukemia
    Martinez-Castillo, Macario
    Gomez-Romero, Laura
    Tovar, Hugo
    Olarte-Carrillo, Irma
    Garcia-Laguna, Anel
    Barranco-Lampon, Gilberto
    De la Cruz-Rosas, Adrian
    Martinez-Tovar, Adolfo
    Hernandez-Zavala, Araceli
    Cordova, Emilio J.
    LEUKEMIA RESEARCH, 2023, 131
  • [37] Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors
    Pietarinen, Paavo O.
    Eide, Christopher A.
    Ayuda-Duran, Pilar
    Potdar, Swapnil
    Kuusanmaki, Heikki
    Andersson, Emma I.
    Mpindi, John P.
    Pemovska, Tea
    Kontro, Mika
    Heckman, Caroline A.
    Kallioniemi, Olli
    Wennerberg, Krister
    Hjorth-Hansen, Henrik
    Druker, Brian J.
    Enserink, Jorrit M.
    Tyner, Jeffrey W.
    Mustjoki, Satu
    Porkka, Kimmo
    ONCOTARGET, 2017, 8 (14) : 22606 - 22615
  • [38] Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia
    Foroni, Letizia
    Gerrard, Gareth
    Nna, Emmanuel
    Khorashad, Jamshid Sorouri
    Stevens, David
    Swale, Bryony
    Milojkovic, Dragana
    Reid, Alistair
    Goldman, John
    Marin, David
    AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (08) : 517 - 522
  • [39] Nilotinib as first-line therapy for chronic myeloid leukemia
    Vaid, A.
    INDIAN JOURNAL OF CANCER, 2011, 48 (04) : 438 - 445
  • [40] Finding the right BCR-ABL1 tyrosine kinase inhibitor: a case report of successful treatment of a patient with chronic myeloid leukemia and a V299L mutation using nilotinib
    Elnair, Radowan
    Galal, Ahmed
    BMC CANCER, 2018, 18
12345